Vanda V. West-Ward: This Time, Dosage Adjustment Claims Are Patent Eligible Subject Matter | Latest News RSS feed

Vanda V. West-Ward: This Time, Dosage Adjustment Claims Are Patent Eligible Subject Matter - Latest News


Federal Circuit Patent Updates - April 2018

The Court also held that the patent covers patent-eligible subject matter under 35 U.S.C. § 101 because the claims are directed to "a new way of using an existing drug," including a "dosage regimen ba... read more

Avadel Pharmaceuticals plc (AVDL)

patents and proprietary rights associated with the Drug may not provide adequate protection; patents licensed to us under our license agreement with Serenity that cover the Drug are subject to litigat... read more

Amarin Corporation PLC (AMRN)

has been subject to such filing requirements for the past 90 days. YES ☑ NO ☐ Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, e... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us